Poster Abstract Session:
51. Diagnostics: Use of Biomarkers
Thursday, October 27, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Tracks: Adult ID

Presentations:
226
Combined Biomarkers Discriminate Mortality Risk Among Critically Ill Patients with Suspected Sepsis
Brendan Kelly, MD, MS ; Ebbing Lautenbach, MD, MPH, MSCE, FIDSA, FSHEA ; Irving Nachamkin, DrPH, MPH, FIDSA ; Susan Coffin, MD, MPH, FSHEA, FPIDS ; Jeffrey S. Gerber, MD, PhD ; Barry Fuchs, MD ; Charles Garrigan, MB ; Xiaoyan Han, MS ; Warren Bilker, PhD ; Jacqueleen Wise, BA ; Pam Tolomeo, MPH ; Jennifer Han, MD, MSCE
227
Three Serum Cytokine Biomarkers Predict Presence of Acute Otitis Media Infection and Recovery from Relevant Otopathogens
Michael Pichichero, MD ; Matthew Morris, PhD ; Anthony Almudevar, PhD
228
Procalcitonin Utilization in Patients Hospitalized with Pneumonia in Michigan Hospitals: A Cohort Study
Valerie Vaughn, MD ; Tejal Gandhi, MD ; Anurag Malani, MD, FIDSA ; Rama Thyagarajan, MD ; Anna Conlon, PhD ; Daniel Nielsen, MS ; Scott Flanders, MD
Posters
  • Procalcitonin ID week poster Updated 1995 patients 10_18.pdf (143.2 kB)
    • 229
    The Epidemiology of Procalcitonin Use in United States Hospitals
    Sameer Kadri, MD ; Chanu Rhee, MD, MPH ; Zhun Cao, PhD ; Scott B. Robinson, MA, MPH ; Craig B. Lipkin, MS ; Samuel Bozzette, MD PhD ; Robert Balk, MD
    230
    Real World Experience with Procalcitonin Use for Lower Respiratory Tract Infections
    Kelley Mcginnis, PharmD ; Kiri Rolek, PharmD ; Trevor C. Van Schooneveld, MD
    Posters
  • ID Week PCT.pdf (630.5 kB)
    • 231
    Procalcitonin and Cellulitis: Cohort Study of the Correlation of Procalcitonin Blood Levels with the Severity and Outcome in Patients with Limb Cellulitis
    Richard Brindle, MD ; Paul Davies, MB BS
    Posters
  • Poster ISDA2016BrindleProcalcitoninC4C1slide.pdf (452.1 kB)
    • 232
    Rhinovirus, Influenza A, and Influenza B and their Impact on MxA, PCT, and CRP Biomarkers
    Robert Sambursky, MD ; Nathan Shapiro, MD
    Posters
  • 232_IDWPOSTER.pdf (67.3 kB)
    • 233
    The L-Index : Can It Predict CMV Reactivation Among Allogeneic Hematopoetic Stem Cell Transplant (HSCT) Recipients?
    Cybele Lara Abad, MD ; Brian Lahr, MS ; John C O'horo, MD ; R Walker, MD ; William Hogan, MD ; Aaron Tande, MD
    Posters
  • L-index FInal.pdf (1.3 MB)
    • 234
    Can procalcitonin and C-reactive protein determine treatment in blood stream infections?
    Firdevs Aksoy, Assistant Professor ; Gürdal Yilmaz, associated professor ; Murat Aydin, assistant ; Selcuk Kaya, Associate Professor ; Ahmet Eroglu, proffessor ; Iftihar Koksal, proffessor
    Posters
  • idweek2016 PCT.pdf (306.1 kB)
    • 235
    The Diagnostic and Prognostic Value of Procalcitonin in Patients with The Diagnosis of SIRS, Sepsis and Septic Shock In Intensive Care Unit
    Tuna Demirdal, Dr ; Pinar Sen, Dr ; Atakan Nemli, Dr
    Posters
  • poster 3.pdf (607.8 kB)
    • 236
    TNF-related Apoptosis-inducing Ligand (TRAIL) Protein as a Marker for Disease Severity in Patients With Acute Infection
    Kfir Oved, PhD ; Asi Cohen, PhD ; Olga Boico, PhD ; Roy Navon, MSc ; Tom Friedman, MD ; Liat Etshtein, MD ; Ellen Bamberger, MD ; Ester Pri-or, MPH ; Tanya Gottlieb, PhD ; Meital Paz, B.Sc. ; Isaac Srugo, MD ; Irina Chistyakov, MD ; Adi Klein, MD ; Israel Potasman, MD, FIDSA ; Eran Eden, PhD
    Posters
  • IDweek 2016_poster-Final.pdf (924.9 kB)

    • CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:


    See more of: Poster Abstract Session
    << Previous Session | Next Session >>

    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.